Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
These facilities are commissioned by Aurobindo's wholly own subsidiary: Lyfius Pharma Private Limited, Qule Pharma Private Limited, Eugia Steriles Private Limited and Auroactive Pharma Private Limited.
This acquisition enables MTD to open new, strategic markets
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
These re-agent and diagnostic test kits come with 99.7% accuracy
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
